Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001790340-26-000105

Chief Financial Officer bought 25,000 shares at $3.58 ($89,500)

From the SEC's structured data for this filing

Trades in this filing

Gengos Andrew · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Purchase : show line 1 in the form +25,000 $3.58 $89,500 250,000 D
Open-market purchases · 25,000 sh · avg $3.58 · $89,500
Loading xslF345X06/wk-form4_1794863256.xml…